Seventh Sense is a deep tech AI company specializing in Computer Vision at the edge. Smart Vision fo
Location: Singapore
Employees: 11-50
Founded date: 2017
Investors 2
| Date | Name | Website |
| - | 500 Startu... | 500.co |
| 13.11.2023 | Cap Vista | capvista.c... |
Mentions in press and media 11
| Date | Title | Description |
| 24.08.2026 | Top DefenceTech Startups In Singapore | National security is being fundamentally transformed in an age of geopolitical uncertainty, contested sea lanes, and rapid technological change. They can’t count on population size or piles of conventional hardware anymore. Instead, the cut... |
| 20.11.2016 | Seventh Sense Biosystems Raises $10M Series C | MEDFORD, Mass.--(BUSINESS WIRE)--Seventh Sense Biosystems, Inc. (7SBio), the makers of TAP™, the world’s first push-button blood collection device, announced a $10M round of Series C funding today. Participating in the financing are existin... |
| 18.11.2016 | Seventh Sense Biosystems Raises $10M in Series C Funding | Seventh Sense Biosystems, Inc. (7SBio), a Medford, MA-based maker of a push-button blood collection device, raised $10M in Series C funding. Backers included existing investors Novartis ($ADR), Laboratory Corporation of America® Holdings, P... |
| 18.11.2016 | Seventh Sense Biosystems Nets $10M Series C | MEDFORD, MA, Seventh Sense Biosystems announced a $10M round of Series C funding. >> Click here for more funding data on Seventh Sense Biosystems >> To export Seventh Sense Biosystems funding data to PDF and Excel, click her... |
| 13.08.2014 | Seventh Sense lands $16M for non-invasive blood collection | Massachusetts-based Seventh Sense Biosystems added 3 new investors this month with the closing of its Series B financing round, which brought in $16 million for the the company’s blood sampling devices. Siemens (NYSE:SI), Novartis and Labor... |
| 13.08.2014 | Seventh Sense Biosystems Raises $16M in Series B Financing | Seventh Sense Biosystems, Inc., a Cambridge, MA-based developer of virtually painless blood collection and diagnostic platforms, raised $16m in Series B financing. Backers included new investors the Venture Capital unit of Siemens Financial... |
| 13.08.2014 | Seventh Sense Biosystems Inks $16M in Series B | CAMBRIDGE, MA, Pioneering developer of virtually painless blood collection and diagnostic platforms, today announced a $16 million Series B financing. >> Click here for more funding data on Seventh Sense Biosystems >> To exp... |
| 13.06.2012 | Seventh Sense Biosystems Closes $10M Series A | CAMBRIDGE, MA, Privately held medical device company developing the novel Touch Activated Phlebotomy (TAP) painless blood sampling system, closed the final tranche of a $10 million series-A financing with existing investors Flagship Ventu... |
| 13.06.2012 | Seventh Sense Biosystems Closes Final Tranche of $10M Series-A Financing | Seventh Sense Biosystems, a Cambridge, MA-based medical device company developing a painless blood sampling system, has closed the final tranche of a $10m Series A financing. Backers include existing investors Flagship Ventures and Polaris ... |
| 16.12.2011 | Seventh Sense Biosystems Receives $3.28M Grant from Bill & Melinda Gates Foundation | Seventh Sense Biosystems, Inc., a Cambridge, MA-based company developing novel blood sampling technology (Touch Activated Phlebotomy™) for decentralized diagnostic testing, has received a $3.28m grant from the Bill & Melinda Gates Found... |
Show more